Brief: Cartesian Therapeutics Inc Q1 Net Income USD -39.182 Million
30/04/2026 12:00
Apr 30 (Reuters) - Cartesian Therapeutics Inc Q1 collaboration revenue USD 78 thousand. Q1 operating expenses USD 26.577 million Q1 operating income USD -26.499 million
Recent news on Cartesian Therapeutics
See all newsBrief: Cartesian Therapeutics Announces Additional Retreatment Data For Descartes-08 Highlighting Deep And Durable Responses In Patients With Myasthenia Gravis
Cartesian Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Cartesian Therapeutics Q2 net income steady
Brief: Cartesian Therapeutics Inc Q2 Net Income USD 15.769 Million
Cartesian Therapeutics Inc expected to post a loss of 87 cents a share - Earnings Preview